Næste

Automatisk afspilning

Dr. Amaria on Genetically Modified TILs in Melanoma

1 Visninger • 07/03/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning